Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee

Jeffery J. Cherian, Javad Parvizi, Dale G. Bramlet, Ka-Heng Lee, D. W. ROMNESS, Michael A. Mont

Osteoarthritis and Cartilage · 2015 · 101 citations · 18 references

DOIFull text

Open access

Concepts

References

18